DaVita Inc (DVA)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:DaVita Inc (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012288
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:93
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). It also focuses on providing integrated health care delivery and management services. It also offers ancillary services, including pharmacy services such as DaVita Rx; infusion therapy services, disease management services; vascular access services; ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. DaVita Medical Group manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, Florida, New Mexico and Colorado. DaVita is headquartered in Colorado, the US.

DaVita Inc (DVA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
DaVita Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
DaVita Inc, Medical Devices Deals, 2011 to YTD 2017 10
DaVita Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
DaVita Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
DSI Renal Acquires Corva Kidney Center Webster from Corva 13
DaVita Healthcare to Acquire Dialysis Units from Arnot Medical for USD7 Million 14
DSI Renal Acquires New Smyrna Beach Artificial Kidney Center In Florida From Kru Medical Ventures 15
Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 16
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 17
Venture Financing 18
Nephrolife Care Raises US$25 Million In Series A Financing 18
Private Equity 19
Frazier Healthcare And New Enterprise Associates To Acquire 30 Dialysis Clinics From DaVita And DSI Renal 19
Partnerships 20
Quintiles Enters into Agreement with DaVita Clinical Research 20
DaVita to Form Joint Venture with Xiaoyi Zhang 21
Genesis Health System Forms Joint Venture with DaVita HealthCare 22
Independence Blue Cross Forms Joint Venture With DaVita HealthCare Partners 23
DaVita Enters Into Joint Venture Agreement With Riches Healthcare 24
3SBio Enters Into Joint Venture Agreement With DaVita For Dialysis Treatment 25
Merger 26
DSI Renal And U.S. Renal Care to Merge 26
Debt Offering 27
DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 27
DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 29
DaVita Completes Public Offering Of Senior Notes Due 2022 For US$1.25 Billion 31
Asset Transactions 33
NextCare Urgent Care Acquires Rio Rancho Urgent Care Center from ABQ Health Partners 33
Acquisition 34
DaVita HealthCare Acquires Remaining Stake in Nephrolife Care 34
DaVita Healthcare Acquires Majority Stake in Express Clinics 35
DaVita HealthCare Partners Acquires Majority Stake In Esensa, Renal Services Provider 36
BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For US$70 Million 37
DaVita Completes Acquisition Of HealthCare Partners, Doctor Network Operator, For Up To US$4.7 Billion 38
DaVita Acquires Lehbi Care, Kidney Care Company 40
DaVita Completes Acquisition Of DSI Renal 41
DaVita Inc – Key Competitors 42
DaVita Inc – Key Employees 43
DaVita Inc – Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Joint Venture 47
Recent Developments 48
Strategy And Business Planning 48
Jun 06, 2017: DaVita Introduces DaVita Health Solutions 48
Financial Announcements 49
Nov 07, 2017: DaVita 3rd Quarter 2017 Results 49
Aug 01, 2017: DaVita Reports 2nd Quarter 2017 Results 51
May 02, 2017: DaVita Reports 1st Quarter 2017 Results 53
Feb 16, 2017: DaVita 4th Quarter 2016 Results 55
Nov 02, 2016: DaVita 3rd Quarter 2016 Results 57
Aug 08, 2016: DaVita HealthCare Partners 2nd Quarter 2016 Results 59
May 04, 2016: DaVita HealthCare Partners 1st Quarter 2016 Results 61
Feb 11, 2016: DaVita HealthCare Partners 4th Quarter 2015 Results 64
Corporate Communications 66
May 24, 2017: DaVita Kidney Care Welcomes Eric Severson as Chief People Officer 66
May 18, 2017: Dr. George R. Aronoff Joins DaVita Kidney Care Physician Leadership Team 67
Apr 10, 2017: DaVita Names New President of International 68
Feb 28, 2017: Dr. Adam Weinstein Joins DaVita Kidney Care Physician Leadership Team 69
Feb 23, 2017: DaVita Appoints Chief Medical Officer for Integrated Kidney Care 70
Jan 05, 2017: DaVita Announces Joel Ackerman to be CFO 71
Jan 05, 2017: DaVita Appoints Pascal Desroches to Board of Directors 72
Dec 21, 2016: “DaVita Way of Giving” Donates Record-breaking $2.2 Million to Local Charities 73
Aug 30, 2016: The Everett Clinic Announces Leadership Transitions 74
Aug 30, 2016: DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team 75
Aug 23, 2016: DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team 76
Jul 13, 2016: DaVita Appoints Phyllis R. Yale to Board of Directors 77
Jul 01, 2016: DaVita HealthCare Partners Names Oraida Roman President of Colorado Springs Health Partners 78
Jun 16, 2016: DaVita Kidney Care Supports New Program from the American Board of Internal Medicine for Nephrologists 79
Jun 13, 2016: Amar Desai, M.D., Returns to DaVita HealthCare Partners 80
May 10, 2016: DaVita Appoints President for Kidney Care Business in Asia Pacific 81
Jan 12, 2016: Chris Miller Joins Paladina Health as Chief Executive Officer 82
Legal and Regulatory 83
Jan 06, 2017: Dialysis Community Seeks Emergency Relief to Block CMS’ Unlawful “Midnight” Rule Harming Patients 83
Aug 17, 2016: DaVita Hospital Services Receives Re-Accreditation from The Joint Commission 84
Mar 09, 2016: DaVita World Headquarters Awarded LEED Platinum Certification by U.S. Green Building Council 85
Government and Public Interest 86
Nov 03, 2017: DaVita Joins Patients in Urging Congress to Pass the Bipartisan Dialysis PATIENTS Demonstration Act 86
Jan 25, 2017: DaVita Responds to US District Court, Eastern District of Texas Ruling Protecting Dialysis Patients from Discrimination by Insurance Companies 87
Other Significant Developments 88
Oct 31, 2017: The Everett Clinic Plays a Leading Role in Addressing Opioid Epidemic 88
May 12, 2017: DaVita Helps Raise Awareness of Mental Illness During Mental Health Month 89
Nov 17, 2016: HealthCare Partners Saves $1.6 million in Anthem Blue Cross Enhanced Personal Health Care Program 90
Oct 31, 2016: DaVita Announces Change for Medicaid Patients Seeking Affordable Care Act Plan Coverage 91
Mar 23, 2016: DaVita Kidney Care Revamps Customized Online Experience for Those Affected by Kidney Disease 92
Appendix 93
Methodology 93
About GlobalData 93
Contact Us 93
Disclaimer 93

List of Tables
DaVita Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
DaVita Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
DaVita Inc, Deals By Therapy Area, 2011 to YTD 2017 9
DaVita Inc, Medical Devices Deals, 2011 to YTD 2017 10
DaVita Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
DSI Renal Acquires Corva Kidney Center Webster from Corva 13
DaVita Healthcare to Acquire Dialysis Units from Arnot Medical for USD7 Million 14
DSI Renal Acquires New Smyrna Beach Artificial Kidney Center In Florida From Kru Medical Ventures 15
Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 16
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 17
Nephrolife Care Raises US$25 Million In Series A Financing 18
Frazier Healthcare And New Enterprise Associates To Acquire 30 Dialysis Clinics From DaVita And DSI Renal 19
Quintiles Enters into Agreement with DaVita Clinical Research 20
DaVita to Form Joint Venture with Xiaoyi Zhang 21
Genesis Health System Forms Joint Venture with DaVita HealthCare 22
Independence Blue Cross Forms Joint Venture With DaVita HealthCare Partners 23
DaVita Enters Into Joint Venture Agreement With Riches Healthcare 24
3SBio Enters Into Joint Venture Agreement With DaVita For Dialysis Treatment 25
DSI Renal And U.S. Renal Care to Merge 26
DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 27
DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 29
DaVita Completes Public Offering Of Senior Notes Due 2022 For US$1.25 Billion 31
NextCare Urgent Care Acquires Rio Rancho Urgent Care Center from ABQ Health Partners 33
DaVita HealthCare Acquires Remaining Stake in Nephrolife Care 34
DaVita Healthcare Acquires Majority Stake in Express Clinics 35
DaVita HealthCare Partners Acquires Majority Stake In Esensa, Renal Services Provider 36
BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For US$70 Million 37
DaVita Completes Acquisition Of HealthCare Partners, Doctor Network Operator, For Up To US$4.7 Billion 38
DaVita Acquires Lehbi Care, Kidney Care Company 40
DaVita Completes Acquisition Of DSI Renal 41
DaVita Inc, Key Competitors 42
DaVita Inc, Key Employees 43
DaVita Inc, Other Locations 45
DaVita Inc, Subsidiaries 46
DaVita Inc, Joint Venture 47

★海外企業調査レポート[DaVita Inc (DVA)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • Owens & Minor, Inc.:企業の戦略・SWOT・財務情報
    Owens & Minor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens & Minor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • eFront S.A.:企業の戦略的SWOT分析
    eFront S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • LinkedIn Corp:企業の戦略的SWOT分析
    LinkedIn Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Porto Seguro SA:企業の戦略・SWOT・財務分析
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Abionic SA:医療機器:M&Aディール及び事業提携情報
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone and iPad, and accessories, among others. Its abioSCOPE in vitr …
  • Carlisle Companies Incorporated:戦略・SWOT・企業財務分析
    Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • RCL Foods Ltd (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Soditech Ingenierie SA (SEC):企業の財務・戦略的SWOT分析
    Soditech Ingenierie SA (SEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Saudi British Bank (1060):企業の財務・戦略的SWOT分析
    The Saudi British Bank (1060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Airbnb Inc:企業の戦略・SWOT・財務情報
    Airbnb Inc - Strategy, SWOT and Corporate Finance Report Summary Airbnb Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Chugoku Marine Paints Ltd (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints Ltd (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genalyte Inc-医療機器分野:企業M&A・提携分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • Energy Development Corp (EDC):企業の財務・戦略的SWOT分析
    Energy Development Corp (EDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Eastern Company SAE:企業の戦略・SWOT・財務情報
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Healx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Healx Ltd (Healx) is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company’s technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. …
  • Ocean Rig UDW Inc (ORIG):企業の財務・戦略的SWOT分析
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆